Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA)

Published:2003-07 Issue:7 Volume:24 Page:1093-1098
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Polianova Maria T.,Ruscetti Francis W.,Pert Candace B.,Tractenberg Rochelle E.,Leoung Gifford,Strang Scott,Ruff Michael R.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference19 articles.

1. A peptide T bolus normalizes growth hormone secretion pattern in two children with AIDS;Barbey-Morel;Peptides,2002

2. Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults;Barbour;J. Virol.,2002

3. The challenge of viral reservoirs in HIV-1 infection;Blankson;Annu. Rev. Med.,2002

4. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors;Condra;Nature,1995

5. CD4+ T-cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy;Deeks;J. Infect. Dis.,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands;The Journal of Biochemistry;2022-06-16

2. B3Pred: A Random-Forest-Based Method for Predicting and Designing Blood–Brain Barrier Penetrating Peptides;Pharmaceutics;2021-08-11

3. Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review);Molecular Medicine Reports;2019-01-10

4. Neuropathic pain inhibitor, RAP-103, is a potent inhibitor of microglial CCL1/CCR8;Neurochemistry International;2018-10

5. HIV, Antiretroviral Therapies, and the Brain;Current HIV/AIDS Reports;2010-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3